ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

• Veronika Navrkalova,
• Emma Young,
• Panagiotis Baliakas,
• Lenka Radova,
• Lesley-Ann Sutton,
• Karla Plevova,
• Larry Mansouri,
• Viktor Ljungström,
• Stavroula Ntoufa,
• Zadie Davis,
• Gunnar Juliusson,
• Karin E. Smedby,
• Chrysoula Belessi,
• Panagiotis Panagiotidis,
• Tasoula Touloumenidou,
• Frederic Davi,
• Anton W. Langerak,
• Paolo Ghia,
• Jonathan C. Strefford,
• David Oscier,
• Jiri Mayer,
• Kostas Stamatopoulos,
• Sarka Pospisilova,
• Richard Rosenquist,
• Martin Trbusek

Affiliations

Veronika Navrkalova

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;Department of Molecular Medicine, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic;Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Emma Young

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Panagiotis Baliakas

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Lenka Radova

Department of Molecular Medicine, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic

Lesley-Ann Sutton

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Karla Plevova

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;Department of Molecular Medicine, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic

Larry Mansouri

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Viktor Ljungström

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Stavroula Ntoufa

Institute of Applied Biosciences, CERTH, Thessaloniki, Greece

Zadie Davis

Department of Molecular Pathology, Royal Bournemouth Hospital, UK

Gunnar Juliusson

Department of Laboratory Medicine, Stem Cell Center, Hematology and Transplantation, Lund University, Sweden

Karin E. Smedby

Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden

Chrysoula Belessi

Hematology Department, General Hospital of Nikea, Piraeus, Greece

Panagiotis Panagiotidis

First Department of Propaedeutic Medicine, School of Medicine, University of Athens, Greece

Tasoula Touloumenidou

Institute of Applied Biosciences, CERTH, Thessaloniki, Greece;Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece

Frederic Davi

Laboratory of Hematology, Hospital Pitie-Salpetriere and University Pierre and Marie Curie, Paris, France

Anton W. Langerak

Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands

Paolo Ghia

Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy

Jonathan C. Strefford

Cancer Sciences, Faculty of Medicine, University of Southampton, UK

David Oscier

Department of Molecular Pathology, Royal Bournemouth Hospital, UK

Jiri Mayer

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic

Kostas Stamatopoulos

Institute of Applied Biosciences, CERTH, Thessaloniki, Greece

Sarka Pospisilova

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;Department of Molecular Medicine, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic

Richard Rosenquist

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Martin Trbusek

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic